GNH USA

Europe — EMA

Memantina Grindeks

GNH USA supplies Memantina Grindeks (Memantine), a NMDA receptor antagonist for Alzheimer's disease treatment. Request a quote for global supply today.

Memantine Hydrochloride

Request sourcing

1
Pack/s

What is Memantine Hydrochloride?

Memantine, the active ingredient in Memantina Grindeks, is a NMDA receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adults.

GNH USA supplies Memantina Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Memantine Hydrochloride used for?

Memantina Grindeks is a NMDA receptor antagonist used in the management of Alzheimer’s disease. - Alzheimer’s disease (moderate to severe): improves cognition and daily functioning. - Alzheimer’s disease (behavioral symptoms): may reduce agitation and aggression. - Alzheimer’s disease (overall disease progression): helps slow functional decline.

What are the side effects of Memantine Hydrochloride?

Memantina Grindeks may cause a range of adverse reactions.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Confusion: temporary mental clouding. - Fatigue: feeling unusually tired. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Seizures: rare occurrence of convulsive episodes. - Allergic reactions: rash, itching, or swelling. - Stevens‑Johnson syndrome: severe skin reaction. - Hepatic dysfunction: abnormal liver enzymes. - Cardiac arrhythmias: irregular heart rhythm. - Psychosis: emergence of hallucinations or delusions.

What precautions apply to Memantine Hydrochloride?

Before initiating therapy, consider the following safety measures. - Renal impairment: assess kidney function and adjust dose if needed. - Hepatic impairment: monitor liver enzymes regularly. - Cardiovascular disease: use with caution in patients with heart conditions. - Concomitant NMDA antagonists: avoid combined use to prevent additive toxicity. - Pregnancy and lactation: risk unknown; discuss with a healthcare professional. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

What does Memantine Hydrochloride interact with?

Memantina Grindeks can interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Amantadine: combined NMDA antagonism may increase neurotoxicity. - Ketamine: additive CNS effects and heightened risk of seizures. - Dextromethorphan: may enhance neuropsychiatric adverse events.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may worsen cognitive side effects. - CNS depressants (e.g., benzodiazepines): increased sedation. - Diuretics: potential for electrolyte imbalance. - Antihypertensives: monitor blood pressure for additive hypotensive effect. - NSAIDs: watch for gastrointestinal irritation.

Frequently asked questions

What is Memantina Grindeks used for?+
Memantina Grindeks contains memantine hydrochloride and is prescribed to treat moderate to severe Alzheimer’s disease. It helps improve cognitive function and daily activities by reducing excitotoxic neuronal damage associated with the disease.
How does memantine work in the brain?+
Memantine works as a non‑competitive antagonist of the NMDA receptor. By blocking excessive calcium entry through the receptor’s ion channel, it reduces glutamate‑induced excitotoxicity, thereby protecting neurons from damage that contributes to Alzheimer’s disease progression.
What is the usual dose of Memantina Grindeks?+
The specific dose and titration schedule for Memantina Grindeks are determined by the prescribing clinician based on the patient’s condition, renal function, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Memantina Grindeks safe during pregnancy or breastfeeding?+
The safety of memantine during pregnancy or lactation has not been fully established. Healthcare providers should weigh potential benefits against unknown risks and discuss alternative options with pregnant or nursing patients.
How do I order Memantina Grindeks from GNH USA?+
To request Memantina Grindeks, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Memantina Grindeks compare with other Alzheimer’s drugs?+
Memantine belongs to the NMDA receptor antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While both classes aim to improve cognition, memantine targets glutamate‑mediated excitotoxicity, and is often used in moderate to severe stages, sometimes in combination with an acetylcholinesterase inhibitor for additive benefit.
What are the storage and handling requirements for Memantina Grindeks?+
Store Memantina Grindeks at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat and direct sunlight to maintain stability and potency throughout its shelf life.
How is Memantina Grindeks administered?+
Memantina Grindeks is taken orally, usually as a tablet, with or without food. The exact administration schedule, including dose titration, is set by the prescriber to match the patient’s therapeutic needs.
What are the most serious risks associated with Memantina Grindeks?+
Serious adverse events, though rare, can include seizures, severe allergic reactions such as Stevens‑Johnson syndrome, hepatic dysfunction, cardiac arrhythmias, and psychotic symptoms. Patients should seek immediate medical attention if any of these occur.
Who should not use Memantina Grindeks?+
Memantina Grindeks should be avoided in patients with known hypersensitivity to memantine or any excipients, and used with caution in those with severe renal or hepatic impairment, uncontrolled cardiovascular disease, or who are taking other NMDA antagonists.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Memantine Hydrochloride
Route
Oral Use
Manufacturer
Grindeks
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU